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ABSTRACT
Background. Neonatal hyperbilirubinemia (HB) may cause severe neurological
damage, but serious consequences are effectively controlled by phototherapy and
blood exchange transfusion. HB is still a serious health problem in economically
compromised parts of the world. The long term outcome has been regarded favorable
based on epidemiological data, but has not been confirmed in prospective follow-up
studies extending to adulthood.
Methods. We studied the long term consequences of HB in a prospective birth cohort
of 128 HB cases and 82 controls. The cases are part of a neonatal at-risk cohort
(n = 1196) that has been followed up to 30 years of age. HB cases were newborns
≥ 2500 g birth weight and≥ 37 weeks of gestation who had bilirubin concentrations
> 340 µmol/l or required blood exchange transfusion. Subjects with HB were divided
into subgroups based on the presence (affected HB) or absence (unaffected HB) of
diagnosed neurobehavioral disorders in childhood, and compared with healthy
controls. Subjects were seen at discharge, 5, 9 and 16 years of life and parent’s and
teacher’s assessments were recorded. At 30 years they filled a questionnaire about
academic and occupational achievement, life satisfaction, somatic and psychiatric
symptoms including a ADHD self-rating score. Cognitive functioning was tested
using ITPA, WISC, and reading and writing tests at 9 years of life.
Results. Compared to controls, the odds for a child with HB having neurobehavioral
symptoms at 9 years was elevated (OR = 4.68). Forty-five per cent of the HB group
were affected by cognitive abnormalities in childhood and continued to experience
problems in adulthood. This was apparent in academic achievement (p < 0.0001)
and the ability to complete secondary (p < 0.0001) and tertiary (p < 0.004) edu-
cation. Also, the subgroup of affected HB reported persisting cognitive complaints
e.g., problems with reading, writing and mathematics. Childhood symptoms of hy-
peractivity/impulsivity (p < 0.0001) and inattention (p < 0.02) were more common
in HB groups, but in adulthood the symptoms were equal. The affected HB had
lower scores in parameters reflecting life satisfaction, less controlled drinking, but not
increased substance abuse.
Discussion. Our results indicate that neonatal HB has negative consequences in
adult age. A prospectively collected cohort with strict inclusion criteria enables
to control most of the bias factors involved with retrospective data. The control
and HB groups were remarkably similar at birth in terms of medical data, and the
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growth environment of the children, as well as the parents’ social groups, education,
size of family, type of housing at birth and at 9 years of age. Our findings bear
resemblance to disorders of the fronto-striatal network, and also symptoms of the
ADHD spectrum were frequent in the HB group suggesting a link of HB to other
neurodevelopmental disorders.
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INTRODUCTION
Neonatal hyperbilirubinemia (HB) is a well-recognized risk for severe neurological
disability and death (Ip et al., 2004). While it is at present reasonably well controlled
in the developed countries, it is still a concern in economically compromised areas
(Sgro, Campbell & Shah, 2006; Kaplan, Bromiker & Hammerman, 2011). The pathogenesis
of encephalopathy by unconjugated bilirubin is poorly understood but neuronal damage
may be linked to oxidative stress and a disruption of the blood–brain barrier (Palmela et
al., 2011). Kernicterus refers to the severe neurodevelopmental consequences, but more
subtle forms of bilirubin encephalopathy also exist (Shapiro, 2003; Johnson & Bhutani,
2011). The type and severity of the effects of HB have mostly been studied in relatively
short follow-up studies ranging up to school age, where mild to moderate neonatal HB has
appeared to be relatively, if not totally, benign (Culley et al., 1970; Newman & Klebanoff,
2002; Ip et al., 2004; Gamaleldin et al., 2011). There is still controversy however on the
risks for neurodevelopmental disorders in later childhood (Shapiro, 2003; Kuzniewicz &
Newman, 2009; Johnson & Bhutani, 2011; Koziol, Budding & Chidekel, 2013). To date, there
are very few studies on neonatal hyperbilirubinemia followed up to early adulthood,
and none beyond 20 years. The existing ones are based on retrospective analysis of
birth data during military drafting of conscripts (Nilsen et al., 1984; Seidman et al., 1991;
Ebbesen et al., 2010).
In a Norwegian study reporting results of 39 male conscripts at 18 years of age, the
mean intelligence scores were comparable to the total conscript cohort, but seven subjects
with a more severe hyperbilirubinemia had significantly lower scores than the national
average (Nilsen et al., 1984). A study from Israel with a much larger sample (n = 1948)
found no linear association between neonatal bilirubin levels and intelligence test scores or
school achievement at 17 years of age, but the risk for low intelligence test scores was higher
among full term males (but not females) with serum bilirubin levels above 342 µmol/l
(Seidman et al., 1991). The most recent study was from Denmark, where no association
between higher bilirubin levels and the risk of obtaining a neuropsychiatric diagnosis, or
scoring lower in the cognitive test used in the drafting was seen in males with a median age
of 18.8 years (Ebbesen et al., 2010). There was however a larger proportion of men found
unfit for military service in the HB group. Also, only 25 subjects (6% of all hyperbilirubin
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cases) in the Danish study were exposed to bilirubin levels above 342 µmol/l, the cut-off
value that has previously been regarded significant.
These studies have mainly relied on IQ data and only offer limited outcome informa-
tion. Intelligence scores are often insensitive to executive dysfunction, learning deficits and
affective disorders (Johnson & Bhutani, 2011). An association between neonatal jaundice
and neurodevelopmental syndromes, e.g., ADHD has been suggested (Jangaard et al.,
2008) but not proven (Kuzniewicz, Escobar & Newman, 2009). Also a link to autism
and other disorders of psychological development has been presented in HB (Jangaard
et al., 2008; Maimburg et al., 2010). In a national cohort from Denmark, full-term
children exposed to jaundice as neonates had 56% to 88% greater risks of psychological
development disorders, compared with children not exposed to jaundice (Maimburg et al.,
2010). The conclusion of HB being of benign nature based on intelligence test findings may
therefore be inaccurate. Very little is known about the vocational and social outcome of
hyperbilirubinemia in adults.
We report here the 30 year results of a prospective follow-up study on a birth cohort
of full term and normal weight newborns with hyperbilirubinemia (HB > 340 µmol/l)
as the only birth risk factor whose adult outcome is compared to healthy, typically
developed controls similarly followed-up. Our aim was to study if the cognitive and
behavioral problems discovered in childhood continue in adulthood, and if they affect
the educational, occupational, and social functioning as well as health and wellbeing of the
adult subjects.
MATERIAL & METHODS
Participants
The birth risk cohort originates from a single maternity hospital in Helsinki, Finland.
During the recruitment period 1971–74, there were 22,359 consecutive births in this
hospital, out of which 1196 (5.4%) neonates had at least one predefined risk: APGAR score
lower than 7 at 5 or 15 min (n= 372), birth weight under 2000 grams (n= 317), jaundice
with bilirubin> 340 µmol/l (n= 368), severe respiratory difficulties necessitating external
ventilation (n = 161), neurological symptoms (n = 195), maternal diabetes (n = 95),
infant hypoglycemia (n= 104), and severe infection (n= 36); 19% had more than one risk
factor (Michelsson et al., 1978).
For the present study only full term neonates with hyperbilirubinemia were included.
For inclusion, at least two serum bilirubin values of 340 µmol/l (20 mg/100 ml) or
more were required. Children who had received blood exchange transfusion because of
rapidly increasing serum bilirubin values were also included. Those who died during early
childhood and those with severe disabilities (incl. kernicterus) were excluded from follow
up (Michelsson, Donner & Lindahl, 1988). Additional exclusion criteria for the present
study included gestational age below 37 weeks, or birth weight below 2500 g. There were
238 HB cases fulfilling these inclusion and exclusion criteria. All subjects were Caucasian
and the families spoke Finnish.
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The control subjects, also prospectively studied from childhood, were born in the same
hospital during the study period, attended the same schools, and were free of any perinatal
risk factors. For the present study those with gestational age at or above 37 weeks, birth
weight at or above 2500 g and full assessment information from 9 years of age are included
(n= 145).
Ethical review has been conducted over the course of the longitudinal study, and the
latest approval was obtained from the Ethical Review Board of the Helsinki and Uusimaa
hospital district in May 2013 (number 147/13/3/00/2013). All participants gave their
written consent to the study.
Methods and procedures
The family’s social and economic status, maternal risk factors, genetic traits, medical data
about delivery and delivery complications was recorded prospectively. The socio-economic
status was defined as the father’s occupational level (1 to 5, 1 being the highest category).
Psychosocial distress score was formed to include poor housing conditions, divorces,
relocations, alcohol abuse, unemployment, family conflicts, domestic violence, imprison-
ment, severe diseases or mental problems in family. Body-mass index was calculated as an
indicator of the general health and development of the child.
The cognitive and behavioral problems in childhood were assessed when the children
were 5 and 9 years of age. This coincides with periods before and after entering school (at
the age of 7 in Finland). The assessment methods have been described in detail elsewhere
(Hokkanen, Launes & Michelsson, 2013). To summarize, a structured neurological
assessment was carried at 5 and at 9 years of age out using the Neurodevelopmental Screen
developed by Michelsson et al. (Michelsson, Ylinen & Donner, 1981; Lindahl, Michelsson
& Donner, 1988). The method is a modification of the test of Bax & Whitmore (1973)
that examines visual acuity, squint, gross motor performance, fine motor performance,
co-ordination and balance, involuntary movements when standing, upper motor neuron
disturbances, articulation, language skills, perception, concentration and behavior.
Other standardized tests and measures used at 5 and/or 9 years of age include the Test
of Motor Impairment (Stott, Moyes & Henderson, 1972), the Dubowitz Intellectual
development screening test (Dubowitz, Leibowitz & Goldberg, 1977) measuring perceptual
and numerical skills, The Illinois Test of Psycholinguistic Abilities (Kirk, McCarthy &
Kirk, 1968), The Draw-a-person test (Goodenough, 1926), the Frostig Developmental Test
of Visual Perception (Frostig, Lefever & Whittlesey, 1966), Reading and spelling tests for
Finnish children (Ruoppila, Roman & Vasti, 1968; Ruoppila, Roman & Vasti, 1969) and
subtests from the Wechsler Intelligence Scale for Children (WISC, Wechsler, 1949).
A questionnaire was filled out by parents both at ages 5 and 9 regarding the parents’
work situation, existing developmental problems or disabilities within the family,
the child’s home environment, development and skill acquisition, illnesses, school
achievement and problem behaviors. The existing problems within the family that were
probed were: delayed speech, delayed motor skills, clumsiness, reading and spelling
difficulties, other school problems, inattention or short temperedness, squint, impaired
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hearing in childhood, mental retardation, mental illnesses and seizures, present or absent
in other family members. In addition, the questionnaire at 5 years included 28 questions
regarding the activity level, motor skills, communication and emotional affectivity of the
child rated in a three point scale. At 9 years of age a questionnaire was also sent to the
teachers concerning school achievement and the need of remedial teaching or a special
class. Additionally, the teacher was asked to perform an evaluation of the pupil’s behavior
and personality in class using 24 adjective pairs (e.g., observant—day dreaming) with a
five point rating between the extremes, as well as five open-ended questions for additional
information.
Based on the comprehensive assessments with measures described above, the children
were classified into either having or not having different developmental disorders. The
decisions were agreed upon at a clinical case conference between a pediatrician, child
neurologist, a psychologist, and a speech therapist, who had performed the assessments.
The results of these 5 and 9 year assessments have been published previously (Lindahl
& Michelsson, 1986; Lindahl & Michelsson, 1987; Lindahl, Michelsson & Donner, 1988;
Michelsson, Ylinen & Donner, 1981; Michelsson, Donner & Lindahl, 1988; Michelsson &
Lindahl, 1984; Michelsson & Lindahl, 1987; Michelsson et al., 1988; Michelsson & Lindahl,
1993; Michelsson & Noronen, 1983). The diagnostic classification in the HB group were as
follows: 21% had minimal brain dysfunction (MBD)—a diagnosis in use at the beginning
of the cohort study defined as three or more concomitant deficits—30% had dyslexia,
27% perceptual disabilities (auditory, visual or undefined), 27% had motor impairment,
15% hyperactivity and attention deficit, 11% significant psychiatric and psychosomatic
symptoms, 9% had neurological signs, and 5% had speech and language abnormalities
(not including dyslalia only). For the purposes of the present study, a combined score of
all the developmental findings was constructed and those with a score of 1 or above were
considered to be affected with at least one of the diagnoses. To analyze the persistence of
symptoms discovered in childhood, the subjects were divided into two groups (affected
and unaffected), based on this classification.
Long term outcome at the age of 30 years was assessed with an extensive questionnaire
prepared for the purposes of this study. Educational outcome was measured by questions
regarding school achievement (graduation from first-level obligatory school, the need
for remedial teaching, the final school grades earned, and the highest degree completed
in secondary or tertiary education). Occupational achievement was measured with a
question about the type of present employment (full-time, part-time, student, maternity
leave, unemployed). Social functioning was assessed with a combined score measuring
social satisfaction (three items) and social contacts (two items), higher value indicating
more dissatisfaction. Life satisfaction, satisfaction with social relationships and satisfaction
with social support received were measured with a 5 point scale (from very satisfied to
very unsatisfied) and the social contact items included reported difficulty in making
friends or maintaining social relationships (yes/no). General health was measured with
a combined score of subjective health (rated with a five-point scale from very good to very
poor), the number of doctors’ appointments (four-point scale), the use of medication for
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physical illnesses, and the presence of headaches or gastro-intestinal complaints (yes/no).
The incidence of past traumas, fractures and concussions was also noted. Substance use
(illicit drugs, alcohol consumption frequency, alcohol related problems) were also included
in the questionnaire as indicators of health and well-being. In addition to categorical
variables, an alcohol consumption score was constructed by combining items of regularly
drinking more than once a month (dichotomized from a six-point scale from never to
daily), excessive use expressed by family members (yes/no), excessive use estimated by self
(yes/no) and reported incidences of driving while intoxicated (yes/no). The psychiatric
status was measured with a combined score of reported psychiatric problems (presence
or absence of depression, anxiety disorder, panic disorder, obsessive-compulsive traits,
manic-depression, or sleep disorders), and the use of prescribed sedatives or hypnotics.
The behavioural outcome was measured with the ADHD Current Symptoms Scale as
well as the ADHD Childhood Symptoms Scale where each of the 18 DSM-IV (American
Psychiatric Association, 1994) diagnostic symptom criteria is scored from 0 to 3 depending
on the severity of symptoms (Barkley & Murphy, 1998). Cognitive outcome was measured
with ongoing cognitive complaints (presence or absence of persisting subjective learning
difficulties, writing difficulties, reading difficulties, perceptual problems, mathematical
problems, speech problems, motor/dexterity problems).
Of the cases fulfilling the criteria of the present study, 128 HB cases (54%) and 82
controls (57%) returned an adequately completed questionnaire at the age of 30 years. See
Fig. 1 for the complete flow chart. We analyzed the possible attrition bias caused by the
54% compliance in the HB group by comparing the responders and the non-responders
(data not shown). At birth, there was no difference between the groups in the parity,
the percentage of small-for-date, apgar points, gestational weeks, birth weight, head
circumference, gender ratio, mother’s smoking habits during pregnancy, or the family
socio-economic status. The developmental classification score at the age of 9 years was
similar in both groups.
Statistical analysis
Statistical analysis was performed using the STATISTICA analysis software (StatSoft, Inc.,
2013). For continuous outcome variables, a multiple analysis of variance (MANOVA)
was used in three separate models that included variables of for birth data, cognitive tests
at 9 years of age, and ADHD symptom scores at 30 years. Missing data was replaced by
mean values of relevant groups. Differences between three groups were further tested by
univariate analysis of variance (ANOVA) and pair-wise comparisons. Due to multiple
comparisons, we used the Bonferroni method post-hoc test because of the conservative
estimates it produces. The Kruskall–Wallis nonparametric analysis of variance was used
for ordinal variables or when the distribution was skewed. For testing significance of two
independent variables, the Mann–Whitney-U or the Kolmogorov–Smirnov two sample
tests were used. Frequencies were calculated from contingency tables and Fisher’s exact test
was used to test the significance in 2× 2 tables.
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Figure 1 Flow chart of the birth risk cohort subjects and controls.
RESULTS AND DISCUSSION
There were 57 HB cases with at least one neurobehavioral disability used for classification
at 9 years of life (the affected-HB group) and 71 with no disabilities (the unaffected-HB
group). The controls were similarly classified into unaffected (n = 70) and affected
(n = 12) groups. The odds ratio was calculated as OR = 4.68 (95% confidence interval
2.21–10.11) for a subject with HB of belonging in the affected group as compared to
controls.
The result indicates that the odds for a subject with neonatal HB being in the affected
group was nearly five-fold compared to the controls. As ADHD, dyslexia and other
developmental disabilities are each found in about 5%–10% of the general population
(Shaywitz & Shaywitz, 2005; Polanczyk et al., 2007; Willcutt et al., 2010), finding individuals
affected with, e.g., reading or writing impairment, motor difficulties, and attentional
problems in our control group as well was expected. HB however greatly increases this risk.
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Table 1 Medical and birth data for the affected and unaffected groups with hyperbilirubinemia (HB) and for the healthy controls. The
significances for differences between the three groups in univariate comparisons are also given.
Affected-HB
n= 57
Unaffected-HB
n= 71
Controls
n= 70
Mean
(95% CI)
Mean
(95% CI)
Mean
(95% CI)
Univariate test across
the three groups
Gestational age (weeks) 39.5
(39.1–39.8)
39.3
(38.9–39.6)
39.8
(39.5–40.2)
ns
Birth weight (g) 3505
(3376–3633)
3469
(3354–3585)
3538
(3428–3649)
ns
Head circumference (cm) 34.6
(34.2–34.9)
35.0
(34.7–35.3)
35.0
(34.7–35.4)
ns
Apgar 1 min 8.6
(8.4–8.8)
8.5
(8.3–8.8)
8.9
(8.7–9.2)
ns
Apgar 5 min 9.8
(9.7–10.0)
9.9
(9.7–10.0)
9.6
(9.4–9.7)
p < 0.002
Apgar 15 min 9.9
(9.9–10.1)
9.9
(9.8–10.0)
10.0
(9.9–10.1)
ns
Maternal age (years) 25.4
(24.3–26.5)
26.0
(25.0–27.0)
26.8
(25.4–28.1)
ns
<300 2 <300 1
300–339 5 300–339 3
340–399 29 340–399 32
400–449 14 400–449 23
Peak bilirubin value,
distribution of cases
>450 3 >450 3
Gender m/f 35/22 39/32 30/40 ns
Notes.
CI, Confidence Interval of the mean.
To study if the neurobehavioral difficulties of childhood improve or disappear in
adulthood, we continued to examine the affected and unaffected subgroup separately. The
subgroups were based on categories that had been formed prospectively, independently
from the present study. Because the aim was to compare the HB group with typically
developed healthy subjects, controls affected with developmental disabilities were excluded
from further analyses. The rationale was that a control group containing both affected and
unaffected individuals would have created a bias in favor of unaffected HB and in disfavor
of affected-HB cases, obscuring the potential differences.
The management of neonatal hyperbilirubinemia
Table 1 shows the perinatal background data in the three groups. A statistically significant
difference was found in MANOVA for the continuous variables (Wilks’ Lambda
p < 0.0001) but in univariate ANOVAs only the 5 min apgar differed between the groups,
with the control group actually being the lowest. There was a slight but statistically not
significant over representation of girls in the control group (57%) and boys in the affected
(61%) and unaffected (55%) HB group.
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No difference between the affected-HB and unaffected HB-groups was found in parity,
the percentage of small-for-date, mother’s smoking habits during pregnancy, maternal
diabetes, the number of X-ray investigations during pregnancy, past miscarriages, maternal
blood pressure, mother’s weight gain during pregnancy, glycosuria, toxemia, mother’s
marital status or the hereditary traits (diabetes, neurological, sensory deficits). Among
all cases with HB, 54 received phototherapy and 79 had blood exchange transfusions
(in six cases more than one transfusion). The number of treatments was equal in the
affected-HB group (46 treated, 11 non-treated) and the unaffected-HB HB group (55
treated, 16 non-treated). Neither were there any significant differences in the start time,
duration of HB or the peak bilirubin value. ABO blood group incompatibility was present
in 40 cases and Rh incompatibility in one. The treated and non-treated HB subjects were
equal in terms of cognitive testing, school performance, and other assessments at 9 years of
age indicating that treatment decisions did not explain the measured outcome differences.
Medical events and development at birth, and 9 years of life
There were no differences in the children’s hospitalizations, traumas, or other somatic
complaints and diseases in follow-up. The body-mass-index BMI of the child was similar
in the three groups at age 9 years (see Table 2). The groups did not differ in the amount of
reported past developmental problems within the family (44% in the affected-HB, 28% in
the unaffected-HB and 34% in the controls).
The family’s socio-economic status was the highest and the social distress scores the
lowest in the unaffected HB group differentiating it from the affected HB group but not
from the control group in pair-wise comparisons. The affected-HB group did not differ
from the controls. The significance levels were low and considering the multiple tests
performed, the findings are not considered meaningful.
The performance of the groups in the Illinois Test of Psycholinguistic Abilities (ITPA),
the Reading and spelling tests as well as the Wechsler Intelligence Scale for Children
(WISC) performed at the age of 9 years is presented in Table 2 demonstrating significant
differences between the three groups (MANOVA Wilks’ lambda p < 0.0001). In pair-wise
comparisons the affected-HB group differed from the controls in all tests conducted; the
unaffected-HB group differed from the controls only in spelling test (p < 0.003). The
frequency of remedial instruction in preschool and school until nine years of age had been
86% in affected-HB, 44% in unaffected-HB, and 28% in the control groups (p < 0.0001).
The results show that despite similar medical history and growth pattern, many children
in the HB group managed less well in the psychological tests than the control group.
This is in line with a previous cross-sectional study of this cohort (Michelsson, Donner
& Lindahl, 1988). In that study, where cases under 2500 g and 35–36 weeks at birth were
also included, half of the HB group presented with writing difficulties at the age of 9 years
(Helenius, 1987). They also had more problems at school, had lower grades, and more often
attended special classes (Michelsson, Donner & Lindahl, 1988). In the present study, where
the pre-term cases were excluded, cognitive tests showed the same result. The mean IQs
were above average in all groups but as the controls performed at a high average range,
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Table 2 Comparison of cognitive functioning, health and family situation in the affected and unaffected groups with hyperbilirubinemia (HB)
as well as the healthy controls at 9 years of age. The significance for differences between the three groups in univariate comparisons is also given.
Affected-HB
n= 57
Unaffected-HB
n= 71
Controls
n= 70
Mean
(95% CI)
Mean
(95% CI)
Mean
(95% CI)
Univariate test across
the three groups
Cognitive functioning
WISC VIQ 104.8
(102.0–107.6)
119.2
(116.6–121.7)
120.0
(117.4–122.5)
p < 0.0001
WISC PIQ 109.1
(106.1–112.2)
118.2
(115.5–121.0)
122.4
(119.7–125.2)
p < 0.0001
WISC FSIQ 107.4
(104.6–110.3)
121.0
(118.4–123.5)
123.3
(120.8–125.9)
p < 0.0001
ITPA total 33.8
(33.0–34.7)
37.7
(36.9–38.4)
37.2
(36.5–38.0)
p < 0.0001
Reading test 8.3
(8.1–8.6)
8.8
(8.6–9.0)
8.8
(8.6–9.0)
p < 0.003
Spelling test 7.0
(6.8–7.3)
7.9
(7.6–8.2)
8.5
(8.3–8.8)
p < 0.0001
Health and family situation
BMI 29.8
(28.5–31.1)
31.6
(30.5–32.7)
31.5
(30.4–32.6)
ns
Social distress score 4.3
(3.4–5.1)
2.7
(2.0–3.4)
3.1
(2.4–3.8)
p < 0.02
Socio-economic status 2.4
(2.1–2.7)
1.9 (1.6–2.1) 2.0
(1.8–2.3)
p < 0.04
Notes.
WISC, Wechsler Intelligence Scale for Children; VIQ, Verbal Intelligence Quotient; PIQ, Performance Intelligence Quotient; FSIQ, Full Scale Intelligence Quotient; ITPA,
Illinois Test of Psycholinguistic Abilities; BMI, Body Mass Index; CI, Confidence Interval of the mean.
possibly due to somewhat outdated norms and the so-called Flynn effect (Flynn, 1987),
the differences were significant. As expected based on the classification performed, the
affected-HB children also needed more special education and help in school. Thus, the
negative effect of HB to cognition was not caused by the borderline cases of low weight and
gestational age.
In contrast to our observations, studies reporting childhood outcomes of HB have
mostly found no significant consequences (Culley et al., 1970; Newman & Klebanoff,
2002; Ip et al., 2004; Gamaleldin et al., 2011). In our cohort 55% of the HB subjects
belonged to the unaffected group and these subjects were comparable to controls in
most variables studied, supporting the general view. However, a smaller percentage was
affected, resembling the cohort in Denmark (Maimburg et al., 2010), emphasizing the need
to identify separate subgroups. Conflicting findings may also depend on the different ages
of children studied. An important factor influencing the clinical picture is the maturation
of frontal cortices, which is not complete until after adolescence, perhaps in the ages
between 15 and 20 years of age (Paus, 2005). The rate of this development is poorly known,
and maturation rates may differ between genders, which should be considered when
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interpreting results of follow-up studies. The association of the cortical maturation with
IQ scores is also unclear (Burgaleta et al., 2014). A third potential factor is the Hawthorne
effect: very active treatment is likely to be given in centers where also research is done,
which may skew results in the direction of less serious consequences.
Academic and occupational achievement reported at 30 years of
age
All but 2 subjects in all groups combined had graduated from first level education (the
first obligatory nine years). However, 11% of the affected-HB subjects reported having
required remedial teaching or a special class during those nine school years, in contrast
to only one child in the control group and none in the unaffected-HB group (p < 0.004).
The proportion of subjects who had received the diploma at the end of the secondary
education (after 12 years of school) was 30% in the affected-HB group, 70% in the
unaffected-HB and 75% in the control group (p < 0.0001). Within the HB group, the
relative risk of not completing secondary education was more than two-fold (RR = 2.49,
95% confidence interval 1.65–3.73, p< 0.0001) for a person with affected-HB compared to
an unaffected-HB.
At the point of school graduation the mean of all school marks (the total average of all
subjects) was significantly different in the three groups F(2,207) = 29.1, p < .0001, the
affected-HB group having the lowest grades and differing from the other two groups in
pair-wise comparison (p < .0001) (see Fig. 2).
The proportion of subjects who by the age of 30 had completed an academic degree
was 11% in the affected-HB group, 32% in the unaffected-HB and 31% in the control
group (p < 0.0001). When other forms of tertiary education (applied universities) were
also included, the relative risk of not completing tertiary education was still elevated
(RR = 1.57, 1.13–2.13, p < 0.004) for a person with affected-HB compared to an
unaffected-HB.
At 30 years of age 86%, 93% and 90% of the groups (affected-HB, unaffected-HB and
controls, respectively) were working or studying full time, showing a similar outcome. At
the other end of the spectrum, however, 11% of the affected-HB, 3% of the controls and
none of the unaffected-HB groups were unemployed (p < 0.006).
The results indicate that the subgroup of affected-HB had poorer academic achieve-
ment, i.e., lower mean school grades, and less potential to graduate from secondary or
tertiary education. There was also a greater risk for later unemployment. Corresponding
findings in academic and occupational failure are reported in other causes of high birth
risk, e.g., low birth weight and asphyxia (Hack & Klein, 2006; Arpino et al., 2010; Stuart,
Otterblad Olausson & Ka¨llen, 2011). The academic achievement is widely regarded as an
objective and a sensitive measure, and it is influenced not only by general intelligence
but also by memory, motivation, executive functions and social skills. A similar course of
underachievement has been found, e.g., in adults with ADHD who may have significantly
less education than expected based on their IQ, and lower occupational levels than
expected based on their education (Biederman et al., 2008).
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Figure 2 Average school grades at school graduation. The average school grades (mean, SEM, 99%
confidence intervals) of subjects with hyperbilirubinemia and controls.
Social functioning, health and substance use at 30 years of age
Marital status and number of offspring was equal in all groups. Still, social dissatisfaction
score was higher (see Table 3) in the affected-HB group compared to the controls in
pair-wise comparison (p < 0.002).
The general health problem score was similar in the three groups and there were no
differences in the reported incidences of traumas, fractures and concussions.
Alcohol consumption was more uncontrolled in the affected-HB group compared
to the controls in pair-wise comparison. Particularly, past episodes of driving while
intoxicated were reported by 20% of the affected-HB group but only by 6% and 9% in
the unaffected-HB and control groups respectively. The use of illicit drugs was similar in
the three groups, 10% of all reported having used at any time in the past.
The results indicate higher alcohol consumption in the affected-HB group. Similar
tendencies in association with developmental deficits have also been observed previously
(Biederman et al., 2008). Excessive alcohol consumption may be a significant confounding
factor in analyzing vocational outcome. The affected-HB group had the highest average in
a score measuring alcohol use but the number of subjects reporting consumption at a level
that could be classified as abuse however was small. There were only a few current users of
illicit drugs at the time the questionnaire was completed and the frequency of ever using
any substance was also low. Incidence of substance abuse in Finland has been among the
Hokkanen et al. (2014), PeerJ, DOI 10.7717/peerj.294 12/20
Table 3 Results from the questionnaire at 30 years for the affected and unaffected groupswith hyperbilirubinemia (HB) aswell as for the healthy
controls. The significance for differences between the three groups in univariate comparisons is also given.
Affected-HB
n= 57
Unaffected-HB
n= 71
Controls
n= 70
Mean
(95% CI)
Mean
(95% CI)
Mean
(95% CI)
Univariate test across
the three groups
Health and well-being
Social dissatisfaction score 3.0
(2.5–3.5)
2.3
(1.9–2.8)
1.8
(1.3–2.3)
p < 0.003
General health problems score 2.4
(2.1–2.8)
2.0
(1.7–2.3)
1.8
(1.5–2.2)
ns
Psychiatric problems score 0.2
(0.1–0.3)
0.08
(0.0–0.2)
0.06
(0.0–0.2)
ns
Alcohol consumption score 2.8
(2.0–3.5)
1.4
(0.7–2.1)
1.6
(0.9–2.3)
p < 0.03
Behavioral functioning
Current inattention symptoms 2.78
(1.97–3.59)
2.56
(1.88–3.24)
1.91
(1.22–2.60)
ns
Current hyperactive–impulsive symptoms 2.96
(2.12–3.80)
2.86
(2.16–3.56)
2.36
(1.65–3.07)
ns
Childhood inattention symptoms 5.52
(4.34–6.70)
2.79
(1.79–3.78)
2.16
(1.15–3.17)
p < 0.0001
Childhood hyperactive–impulsive symptoms 4.40
(3.26–5.53)
2.68
(1.72–3.63)
2.25
(1.28–3.21)
p < 0.02
Cognitive functioning
Subjective persisting problems present absent 13 (23%)
43 (77%)
7 (10%)
64 (90%)
5 (7%)
64 (93%)
p < 0.03
Notes.
CI, Confidence Interval of the mean.
lowest in Europe for decades, although a rise has occurred in the last 10 years (Varjonen et
al., 2012). We conclude that alcohol and substance abuse does not explain the differences
observed in vocational outcome.
Cognitive and psychiatric status at 30 years of age
Ongoing cognitive problems, all symptoms combined, were more frequent in the
affected-HB group compared to the two other groups (Table 3). Sixteen per cent of
the affected-HB group reported reading difficulty, 9% writing, 9% speech and 9%
mathematical difficulty, and smaller percentages other learning or perceptual problems.
In the subjective ADHD symptom rating scales (see Table 3) the three groups differed
significantly (MANOVA Wilks’ lambda, p < 0.004). The affected-HB group scored higher
for childhood inattention compared to both the unaffected-HB and the control groups
(p < 0.001), and also higher for childhood hyperactivity/impulsivity compared to the
controls (p < 0.01). The unaffected-HB group scored higher in childhood inattention
compared to the controls (p < 0.002). The difference was not significant for the current
symptoms rating scales.
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No differences in number of self-reported psychiatric problems between the groups
were found. The use of sedatives or hypnotics was reportedly similar in all groups.
The results indicate that the various learning disabilities found in a subgroup of the HB
cases in childhood continue into adulthood. In our study, 23% of the affected-HB subjects
reported persisting cognitive complaints at the age of 30 years, reading difficulties being
reported most frequently. This is in line with the previous results at 9 years of age (Helenius,
1987). In addition to learning disabilities, the subjects reported subjective ADHD symp-
toms more frequently than the controls. In the retrospective childhood ADHD symptom
rating scale both HB groups (affected and unaffected) reported higher scores of inattention
than controls, but the difference was no longer significant in adulthood. The childhood
hyperactive/impulsive symptoms were higher in the affected-HB group, but they too
levelled off by adulthood, resembling the typical pattern for ADHD symptoms (Biederman,
Mick & Faraone, 2000; Wilens, Biederman & Spencer, 2002). ADHD is suggested to be
more common among subjects with pre- and perinatal risk factors (Strang-Karlsson et
al., 2008; Gustafsson & Ka¨lle´n, 2011; Halmøy et al., 2012) although contradictory findings
have also been reported (Silva, Colvin & Hagemann, 2013). Similarly mixed evidence has
emerged regarding the link between ADHD and hyperbilirubinemia (Jangaard et al., 2008;
Kuzniewicz, Escobar & Newman, 2009). In our study, the ADHD diagnosis cannot reliably
be made based on questionnaire data, but ADHD symptoms appeared to be a part of the
disability spectrum.
CONCLUSIONS
Our aim was to study long term consequences of neonatal hyperbilirubinemia at 30
year-old adults followed up from birth. To exclude the confounding effects of preterm
birth, we included only newborns ≥ 2500 g birth weight and ≥ 37 weeks of gestation.
The subjects with neonatal hyperbilirubinemia were divided into subgroups based on the
presence (affected HB) or absence (unaffected HB) of diagnosed cognitive or behavioral
disabilities in childhood, and compared with healthy controls. Our results indicate that
neonatal HB has negative consequences in adult age. Nearly half of the HB group were
affected by cognitive abnormalities in childhood and continued to experience problems
in adulthood. This was apparent in academic achievement and the ability to complete
secondary and tertiary education. Also, the subgroup of affected HB reported persisting
cognitive complaints, e.g., problems with reading, writing and calculus. Childhood
symptoms of hyperactivity/impulsivity and inattention were more common in HB
groups, but in adulthood the symptom levels were equal. The affected HB still perceived
lower levels of subjective wellbeing as well as social adaptability, and reported more
poorly controlled drinking; findings that may reflect a more profound tendency of poor
adjustment.
The strength of our study is that our control and HB groups were remarkably similar
at birth in terms of medical data and absence of risk factors, other than HB. Our base
cohort’s limit for inclusion in the low birth weight group was 2000 g and inclusion to
any group did not have a fixed limit of weeks of gestation. Consequently, there were a
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few neonates both in the control and the HB groups, whose gestational age was 35–36
weeks and/or birthweight between 2000 and 2500 g. In order to avoid any further bias we
also excluded these borderline cases. The growth environment of the children was also
very similar in the groups, as the parents’ social status, education, size of family, type of
housing were comparable at birth and at 9 years of age. Further, the children were born
in the same hospital, lived in the same metropolitan area, and attended the same schools.
We also tested for attritional bias, and found none. Therefore we think that confounding
factors are well controlled without need for statistical modeling. Our results should be
well generalizable in otherwise uncomplicated HB cases, even in the era of more modern
therapeutic possibilities.
A limitation in our study is that a questionnaire is a rather insensitive tool that has
sampling and data processing challenges (Gilbody, House & Sheldon, 2001; Olsen et al.,
2001; Jaddoe et al., 2006; Jaddoe et al., 2010). However, mailed inquiries are widely used and
allow statistical comparison of parallel groups. Furthermore, in our study the cases had
also been clinically carefully examined from birth up to age 9 years, which increases the
reliability of our data. The main outcomes reported here, i.e., need for remedial teaching,
low school grades and academic underachievement, are objective and we regard the
differences between our groups credible. Still, although statistically significant differences
were found, the results are indicative rather than proof of specific types of cognitive
consequences due to the low specificity of a questionnaire.
The symptoms we found, e.g., decreased social adjustment, symptoms of the ADHD
spectrum, and the ability to achieve goals when in an instructive environment (primary
education with special tuition) but not when independent planning and execution of
tasks are required (higher education or occupational environment) bear resemblance
to impairment of the fronto-striatal system. The pathogenesis of encephalopathy by
unconjugated bilirubin is poorly understood but it seems to involve oxidative stress,
a disruption of the blood–brain barrier and the consequent damage of neuronal cells
(Palmela et al., 2011). Brain pathology typically following bilirubin neurotoxicity has been
suggested to involve the basal ganglia, particularly globus pallidus, as well as subthalamic
nuclei, hippocampus, diencephalon, midbrain, pontine and brain stem nuclei and
cerebellum (Johnson & Bhutani, 2011; Koziol, Budding & Chidekel, 2013), locations which
take part in a wide variety of motor, sensory and cognitive functions. Fronto-subcortical
circuits (Cummings, 1993) connect the frontal cortex to the basal ganglia and these circuits
participate in executive functions (attention control, response inhibition, planning and
execution). In this respect, HB has common elements with the processes that are active in
other perinatal disorders that cause brain damage, e.g., ischemia-asphyxia and immaturity
and/or low birth weight (e.g., Volpe, 2005; Volpe, 2012). Clearly, speculations on frontal
dysfunction in HB warrant further studies with thorough neuropsychological testing and
neuroimaging.
We conclude that neonatal HB is a recognizable cause of adult age neurobehavioral
problems, severe enough to have negative occupational and quality of life effects.
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